科研製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/07/24 | 3,538 | 3,546 | 3,517 | 3,522 | +21 | +0.6% | 77,800 |
| 2023/07/21 | 3,488 | 3,509 | 3,483 | 3,501 | +13 | +0.4% | 87,000 |
| 2023/07/20 | 3,531 | 3,533 | 3,486 | 3,488 | -45 | -1.3% | 149,100 |
| 2023/07/19 | 3,522 | 3,533 | 3,498 | 3,533 | +30 | +0.9% | 108,800 |
| 2023/07/18 | 3,503 | 3,532 | 3,490 | 3,503 | +7 | +0.2% | 78,500 |
| 2023/07/14 | 3,488 | 3,498 | 3,474 | 3,496 | +10 | +0.3% | 133,700 |
| 2023/07/13 | 3,500 | 3,511 | 3,482 | 3,486 | -14 | -0.4% | 103,300 |
| 2023/07/12 | 3,499 | 3,514 | 3,481 | 3,500 | -1 | ±0% | 120,100 |
| 2023/07/11 | 3,529 | 3,536 | 3,491 | 3,501 | -31 | -0.9% | 185,300 |
| 2023/07/10 | 3,535 | 3,551 | 3,519 | 3,532 | -13 | -0.4% | 126,700 |
| 2023/07/07 | 3,552 | 3,573 | 3,537 | 3,545 | -23 | -0.6% | 85,000 |
| 2023/07/06 | 3,573 | 3,602 | 3,560 | 3,568 | -20 | -0.6% | 121,100 |
| 2023/07/05 | 3,574 | 3,600 | 3,562 | 3,588 | +26 | +0.7% | 96,300 |
| 2023/07/04 | 3,600 | 3,608 | 3,500 | 3,562 | -60 | -1.7% | 248,700 |
| 2023/07/03 | 3,620 | 3,649 | 3,610 | 3,622 | +20 | +0.6% | 83,100 |
| 2023/06/30 | 3,630 | 3,639 | 3,596 | 3,602 | -37 | -1% | 114,100 |
| 2023/06/29 | 3,677 | 3,677 | 3,627 | 3,639 | -39 | -1.1% | 69,500 |
| 2023/06/28 | 3,616 | 3,678 | 3,616 | 3,678 | +49 | +1.4% | 90,500 |
| 2023/06/27 | 3,646 | 3,646 | 3,610 | 3,629 | -17 | -0.5% | 78,800 |
| 2023/06/26 | 3,657 | 3,667 | 3,611 | 3,646 | -7 | -0.2% | 42,900 |
| 2023/06/23 | 3,670 | 3,673 | 3,635 | 3,653 | -18 | -0.5% | 64,500 |
| 2023/06/22 | 3,673 | 3,695 | 3,666 | 3,671 | +3 | +0.1% | 63,400 |
| 2023/06/21 | 3,667 | 3,700 | 3,662 | 3,668 | -11 | -0.3% | 96,200 |
| 2023/06/20 | 3,674 | 3,683 | 3,651 | 3,679 | -15 | -0.4% | 84,200 |
| 2023/06/19 | 3,683 | 3,704 | 3,672 | 3,694 | +13 | +0.4% | 70,800 |
| 2023/06/16 | 3,602 | 3,682 | 3,601 | 3,681 | +80 | +2.2% | 249,000 |
| 2023/06/15 | 3,615 | 3,618 | 3,601 | 3,601 | -19 | -0.5% | 76,400 |
| 2023/06/14 | 3,667 | 3,667 | 3,616 | 3,620 | -24 | -0.7% | 78,700 |
| 2023/06/13 | 3,676 | 3,676 | 3,635 | 3,644 | -28 | -0.8% | 80,300 |
| 2023/06/12 | 3,691 | 3,715 | 3,662 | 3,672 | +3 | +0.1% | 92,800 |
| 2023/06/09 | 3,679 | 3,687 | 3,655 | 3,669 | +50 | +1.4% | 168,000 |
| 2023/06/08 | 3,633 | 3,653 | 3,594 | 3,619 | -13 | -0.4% | 91,200 |
| 2023/06/07 | 3,660 | 3,686 | 3,628 | 3,632 | -18 | -0.5% | 101,800 |
| 2023/06/06 | 3,628 | 3,658 | 3,598 | 3,650 | +22 | +0.6% | 84,300 |
| 2023/06/05 | 3,639 | 3,671 | 3,618 | 3,628 | +43 | +1.2% | 127,300 |
| 2023/06/02 | 3,520 | 3,585 | 3,520 | 3,585 | +85 | +2.4% | 91,300 |
| 2023/06/01 | 3,515 | 3,520 | 3,490 | 3,500 | ±0 | ±0% | 146,000 |
| 2023/05/31 | 3,535 | 3,545 | 3,485 | 3,500 | -60 | -1.7% | 198,500 |
| 2023/05/30 | 3,580 | 3,590 | 3,535 | 3,560 | -25 | -0.7% | 110,200 |
| 2023/05/29 | 3,620 | 3,620 | 3,585 | 3,585 | -10 | -0.3% | 61,500 |
| 2023/05/26 | 3,640 | 3,640 | 3,595 | 3,595 | -35 | -1% | 104,200 |
| 2023/05/25 | 3,655 | 3,680 | 3,630 | 3,630 | -35 | -1% | 95,900 |
| 2023/05/24 | 3,660 | 3,670 | 3,650 | 3,665 | -15 | -0.4% | 75,900 |
| 2023/05/23 | 3,735 | 3,745 | 3,660 | 3,680 | -35 | -0.9% | 108,900 |
| 2023/05/22 | 3,705 | 3,730 | 3,680 | 3,715 | +10 | +0.3% | 69,000 |
| 2023/05/19 | 3,700 | 3,740 | 3,685 | 3,705 | +5 | +0.1% | 72,400 |
| 2023/05/18 | 3,780 | 3,780 | 3,695 | 3,700 | -80 | -2.1% | 95,700 |
| 2023/05/17 | 3,785 | 3,810 | 3,770 | 3,780 | -10 | -0.3% | 77,600 |
| 2023/05/16 | 3,710 | 3,790 | 3,710 | 3,790 | +100 | +2.7% | 81,800 |
| 2023/05/15 | 3,690 | 3,705 | 3,660 | 3,690 | +45 | +1.2% | 75,200 |
201～
250
件表示中 / 3458件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 科研薬 | 344,000円 | +4.2% | -21.6% | 4.36% | 23.26倍 | 0.91倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| 日本新薬 | 369,300円 | +1.2% | -6.3% | 3.36% | 10.15倍 | 1.13倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| ペプチド | 191,500円 | +56.7% | +357.2% | 0.00% | 17.73倍 | 6.15倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| キッセイ薬 | 316,000円 | +9.8% | -12.1% | 2.85% | 12.36倍 | 0.63倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| 東和薬品 | 273,000円 | +14.7% | -28.1% | 2.20% | 11.58倍 | 0.86倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
市場注目の銘柄
チャート関連のコラム
